TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32768588

Group type: EXPERIMENTAL
Intervention: SRP + multiple PDT
Number of subjects: 33

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 33
Study: 35988664

Group type: EXPERIMENTAL
Intervention: artemisinin-piperaquine (AP)
Number of subjects: 238

Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL)
Number of subjects: 238
Study: 32770240

Group type: EXPERIMENTAL
Intervention: AVIFAVIR (favipiravir)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35932158

Group type: EXPERIMENTAL
Intervention: Amino acid mixture (nine essential amino acids)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 34890837

Group type: EXPERIMENTAL
Intervention: Helping relationships intervention strategies provided to significant others for 12 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 34431624

Group type: EXPERIMENTAL
Intervention: Mifflin-St-Jeor equation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Harris-Benedict equation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Owen equation
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: World Health Organization/Food and Agriculture equation
Number of subjects: 66
Study: 34075713

Group type: EXPERIMENTAL
Intervention: High activity level group (HA group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low activity level group (LA group)
Number of subjects: 22
Study: 34217297

Group type: EXPERIMENTAL
Intervention: IVIG administered over 12 hours (12H group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: IVIG administered over 24 hours (24H group)
Number of subjects: 39
Study: 35136598

Group type: EXPERIMENTAL
Intervention: Online professional development course about responsive caregiving
Number of subjects: 181

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 181
Study: 34872087

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia + Circadian Rhythm Support (CBT-I+CRS)
Number of subjects: 132

Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 132
Study: 32432795

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Training (2-hour workshop + 4 weeks of guided self-practice)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 224
Study: 33939347

Group type: EXPERIMENTAL
Intervention: Antihistamine + Probiotic (LactoCare)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Antihistamine (Control)
Number of subjects: 42
Study: 36090831

Group type: EXPERIMENTAL
Intervention: Community-based malaria testing
Number of subjects: 5756

Group type: EXPERIMENTAL
Intervention: Testing positive for malaria
Number of subjects: 5756

Group type: EXPERIMENTAL
Intervention: Testing negative for malaria
Number of subjects: 5756

Group type: EXPERIMENTAL
Intervention: Malaria-negative participants
Number of subjects: 5756
Study: 34075879

Group type: EXPERIMENTAL
Intervention: Self-weighing (mean percentage of days with self-weighing: 39.98%, equivalent to 2.8 self-weighs per week)
Number of subjects: 9768

Group type: EXPERIMENTAL
Intervention: Self-weighing (during breaks of ≥30 days without weight measurements)
Number of subjects: 9768
Study: 32801436

Group type: COMPARATOR
Intervention: EECP Therapy
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: TMZ 35 mg twice daily + EECP Therapy
Number of subjects: 88
Study: 33896356

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg/2 mL pre-filled syringe
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Self-Injection Assessment Questionnaire (SIAQ)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Instructions for Use (IFU)
Number of subjects: 214
Study: 32258131

Group type: EXPERIMENTAL
Intervention: Uric acid levels (measured as standard deviation increase)
Number of subjects: 1381

Group type: EXPERIMENTAL
Intervention: Uric acid levels (unadjusted and adjusted analyses)
Number of subjects: 1381

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis using variation at rs11722228 (SLC2A9) as an instrument for uric acid
Number of subjects: 1381
Study: 35815886

Group type: EXPERIMENTAL
Intervention: Transanal total mesorectal resection (taTME)
Number of subjects: 1115

Group type: COMPARATOR
Intervention: Laparoscopic total mesorectal excision (laTME)
Number of subjects: 1115
Study: 33422022

Group type: EXPERIMENTAL
Intervention: Caregiver-child interaction
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Access to books and complex toys
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Singing to children
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Perceived learning value of activities
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Use of songs for promoting ECD
Number of subjects: 30
Study: 32318781

Group type: EXPERIMENTAL
Intervention: Reasoning and Rehabilitation (R&R2) program
Number of subjects: 213

Group type: COMPARATOR
Intervention: treatment as usual (TAU)
Number of subjects: 213
Study: 35092972

Group type: EXPERIMENTAL
Intervention: Conventional opioid general anesthesia (group A)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Reducing-opioids general anesthesia (group B)
Number of subjects: 123
Study: 34471708

Group type: EXPERIMENTAL
Intervention: Positive psychology interventions (PPI) - 10 weekly training sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine prenatal care (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Positive psychology interventions (PPI)
Number of subjects: 40
Study: 32087338

Group type: EXPERIMENTAL
Intervention: Attendance‐Only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight‐Loss Only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both Attendance and Weight‐Loss
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no incentives)
Number of subjects: 0
Study: 33461829

Group type: EXPERIMENTAL
Intervention: Monitoring and Treatment Referral (MTR)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: quarterly RMC (RMC‐Q)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: RMC‐A
Number of subjects: 750

Group type: COMPARATOR
Intervention: RMC‐Q/RMC‐A
Number of subjects: 750

Group type: COMPARATOR
Intervention: MTR vs. RMC‐Q vs. RMC‐A
Number of subjects: 750
Study: 32244111

Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36167851

Group type: EXPERIMENTAL
Intervention: Opt-out protocol for antibiotic de-escalation
Number of subjects: 767

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 767
Study: 34190191

Group type: EXPERIMENTAL
Intervention: GCWB106 for 12 weeks
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 121
Study: 33078727

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg and amoxicillin 1 g bid during the early half of treatment, followed by esomeprazole 40 mg with levofloxacin 500 mg and tinidazole 500 mg bid during the second half of treatment (Group A)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg and amoxicillin 1 g bid during the early half of treatment, followed by esomeprazole 40 mg with clarithromycin 500 mg bid during the second half of treatment (Group B)
Number of subjects: 186
Study: 35320121

Group type: EXPERIMENTAL
Intervention: PPC training + EPC
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: PPC training + SOC
Number of subjects: 360

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 360
Study: 35331179

Group type: EXPERIMENTAL
Intervention: Personality functioning dimensions (Identity integration)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Personality trait dimensions (Disinhibition)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Personality trait dimensions (Negative affect)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Personality pathology overall
Number of subjects: 138
Study: 34369902

Group type: EXPERIMENTAL
Intervention: olanzapine (10 mg) + miricorilant (600 mg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: olanzapine (10 mg) + placebo
Number of subjects: 66
Study: 33125405

Group type: EXPERIMENTAL
Intervention: Blood Gas Analysis (BGA) using ABL800 Flex analyzer® and GEM series®
Number of subjects: 963

Group type: EXPERIMENTAL
Intervention: Blood Gas Analysis (BGA) using RapidPoint 500®
Number of subjects: 963

Group type: COMPARATOR
Intervention: Smoker status
Number of subjects: 963

Group type: COMPARATOR
Intervention: BMI
Number of subjects: 963

Group type: COMPARATOR
Intervention: RBC transfusion
Number of subjects: 963

Group type: COMPARATOR
Intervention: Statins
Number of subjects: 963

Group type: COMPARATOR
Intervention: Beta blocker
Number of subjects: 963

Group type: COMPARATOR
Intervention: Intraoperative substitution of volume and other co-medications
Number of subjects: 963
Study: 35777057

Group type: EXPERIMENTAL
Intervention: Closed flap technique
Number of subjects: 8

Group type: COMPARATOR
Intervention: Open flap technique
Number of subjects: 8
Study: 33917058

Group type: EXPERIMENTAL
Intervention: Higher boundary ambiguity
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Boundary ambiguity
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Overall model for somatization
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Boundary ambiguity and missing family members
Number of subjects: 47
Study: 33911859

Group type: EXPERIMENTAL
Intervention: Ensifentrine 0.375 mg + tiotropium
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Ensifentrine 3 mg + tiotropium
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Ensifentrine 1.5 mg + tiotropium
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo + tiotropium
Number of subjects: 416
Study: 33439085

Group type: EXPERIMENTAL
Intervention: Specialised oral nutritional supplement (ONS) containing arginine and proline, high in vitamins A, C, E, zinc, and selenium, 200ml twice daily for four weeks.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Specialised ONS (for patients with diabetes).
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Specialised ONS (for patients without diabetes).
Number of subjects: 30
Study: 32306982

Group type: EXPERIMENTAL
Intervention: ABC ANSWERS intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine Veterans Health Administration (VHA) primary care
Number of subjects: 200
Study: 34890830

Group type: EXPERIMENTAL
Intervention: Wood-based materials (lower thermal effusivity)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lacquered solid wood
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oak-based materials
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Surface treatment of materials
Number of subjects: 16
Study: 35690752

Group type: EXPERIMENTAL
Intervention: Nomogram model for overall survival (OS) based on seven independent predictors: age, degree of differentiation, T stage, chemotherapy, number of sampled lymph nodes, number of positive lymph nodes, and tumor size.
Number of subjects: 1250

Group type: EXPERIMENTAL
Intervention: Nomogram model for cancer-specific survival (CSS) based on three independent predictors: T stage, chemotherapy, and tumor size.
Number of subjects: 1250

Group type: EXPERIMENTAL
Intervention: Nomogram model for OS and CSS.
Number of subjects: 1250
Study: 34229916

Group type: EXPERIMENTAL
Intervention: Less invasive surgery (LIS)
Number of subjects: 107
Study: 33941083

Group type: EXPERIMENTAL
Intervention: Hatha Yoga
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine prenatal care
Number of subjects: 70
Study: 32169524

Group type: EXPERIMENTAL
Intervention: Social exclusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Social inclusion/control
Number of subjects: 40
Study: 35618855

Group type: EXPERIMENTAL
Intervention: Intravesical aminophylline instillation (IVAI)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Balloon dilatation
Number of subjects: 83
Study: 34033447

Group type: EXPERIMENTAL
Intervention: Premature infant oral motor intervention (PIOMI)
Number of subjects: 60
Study: 32910555

Group type: EXPERIMENTAL
Intervention: Free Maternal and Child Health (FMCH) programme
Number of subjects: 584
Study: 33616337

Group type: EXPERIMENTAL
Intervention: Platelet count assessment over 14 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Assessment of outcomes classified by the modified Rankin Scale (mRS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Platelet aggregability assessment by multiple electrode aggregometry (MEA)
Number of subjects: 18
Study: 32080862

Group type: EXPERIMENTAL
Intervention: Treprostinil iontophoresis (1 mg/mL hydrogel)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo iontophoresis
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Treprostinil iontophoresis
Number of subjects: 5
Study: 35725562

Group type: EXPERIMENTAL
Intervention: Training and onsite mentorship
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (no training or mentorship)
Number of subjects: 216
Study: 34382846

Group type: EXPERIMENTAL
Intervention: Two-hour turning schedule
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Three-hour turning schedule
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Four-hour turning schedule
Number of subjects: 44
Study: 34919831

Group type: EXPERIMENTAL
Intervention: Ivermectin (300-400 μg/kg per day for 3 consecutive days) and dihydroartemisinin-piperaquine (dosage depending on body weight) plus standard control interventions
Number of subjects: 10638

Group type: COMPARATOR
Intervention: Standard control interventions
Number of subjects: 10638

Group type: EXPERIMENTAL
Intervention: Ivermectin and dihydroartemisinin-piperaquine
Number of subjects: 10638
Study: 36335783

Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg QD (arm A)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Regorafenib 120 mg QD (arm B)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg QD 1 week on/1 week off (arm C)
Number of subjects: 299
Study: 34817519

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic donor nephrectomy (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard laparoscopic donor nephrectomy (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic donor nephrectomy (Group 3)
Number of subjects: 60
Study: 32668474

Group type: EXPERIMENTAL
Intervention: Radiotherapy (median dose of 59.4Gy within 2 months after ESD)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-radiotherapy (regular follow-up only)
Number of subjects: 70
Study: 34379996

Group type: EXPERIMENTAL
Intervention: Physical dance training with 'Dance Central' game for Xbox 360® with Kinect, 3 sessions of 40 minutes each week for 12 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (maintained usual activities of daily living)
Number of subjects: 46
Study: 35139271

Group type: EXPERIMENTAL
Intervention: Ad26.COV2.S (5×10^10 viral particles)
Number of subjects: 39185
Study: 36377172

Group type: EXPERIMENTAL
Intervention: Listerine Cool Mint (alcohol-based mouthwash)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Colgate Plax (mouthwash)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Clinica (mouthwash)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Nanocomposite (Z350XT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Microhybrid (P60)
Number of subjects: 64
Study: 32554843

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Inactive control group (CON)
Number of subjects: 29
Study: 35971138

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Delayed enteral nutrition (DEN)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both EEN and DEN
Number of subjects: 80
Study: 33771149

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 98

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 98
Study: 35851686

Group type: EXPERIMENTAL
Intervention: Self-compassion intervention
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cognitive dissonance intervention
Number of subjects: 101

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 101
Study: 34857536

Group type: EXPERIMENTAL
Intervention: Boys with exon 8 skippable deletions
Number of subjects: 196

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 196
Study: 33803970

Group type: EXPERIMENTAL
Intervention: Modified research methods for nutrition during pregnancy, infancy, and early childhood
Number of subjects: 0
Study: 36111391

Group type: EXPERIMENTAL
Intervention: D-RVd
Number of subjects: 201

Group type: COMPARATOR
Intervention: RVd
Number of subjects: 201
Study: 34139269

Group type: EXPERIMENTAL
Intervention: Social support cue (support figure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo (ergogenic supplement)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (stranger cue)
Number of subjects: 0
Study: 32766779

Group type: EXPERIMENTAL
Intervention: Manual therapy (3 sessions of physical therapy including desensitization maneuvers and tendon/nerve gliding exercise program)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Surgery (carpal tunnel release)
Number of subjects: 120
Study: 36477716

Group type: EXPERIMENTAL
Intervention: Outpatient Foley catheter (CF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient Foley catheter (CF)
Number of subjects: 0
Study: 33631943

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (2 sessions/week for 8 weeks)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sham stimulation (2 sessions/week for first 4 weeks) followed by intermittent theta burst stimulation (2 sessions/week for next 4 weeks)
Number of subjects: 78
Study: 33613539

Group type: EXPERIMENTAL
Intervention: tCRM score for acute rejection (AR)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: tCRM score for borderline rejection (BL)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: tCRM score for stable biopsies
Number of subjects: 124

Group type: COMPARATOR
Intervention: Comparison of tCRM scores between pathologists finding inflammation vs. disagreement
Number of subjects: 124

Group type: COMPARATOR
Intervention: Comparison of tCRM scores between pathologists finding inflammation vs. both finding no inflammation
Number of subjects: 124

Group type: COMPARATOR
Intervention: Overall significance among all histologic groups
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Logistic regression model predicting graft inflammation
Number of subjects: 124
Study: 35679656

Group type: COMPARATOR
Intervention: Air
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Saline
Number of subjects: 480
Study: 33069062

Group type: EXPERIMENTAL
Intervention: 53-gene prognostic score system
Number of subjects: 540

Group type: COMPARATOR
Intervention: Other chemotherapies
Number of subjects: 540
Study: 33572618

Group type: EXPERIMENTAL
Intervention: Early physiotherapy program (functional exercises, scar manual therapy, educational tips)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study: 32483998

Group type: EXPERIMENTAL
Intervention: Intraoperative FiO2
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Intraoperative SpO2
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: First intraoperative PaO2
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Second intraoperative PaO2
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Postoperative PaO2
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Hyperoxaemia incidence (first ABG)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Hyperoxaemia incidence (second ABG)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Hyperoxaemia incidence (postoperative ABG)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: PaO2 >200 mmHg (first ABG)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: PaO2 >200 mmHg (second ABG)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: PaO2 >200 mmHg (postoperative ABG)
Number of subjects: 373
Study: 33039585

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 142
Study: 33972647

Group type: EXPERIMENTAL
Intervention: LUCAS-2
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 32439008

Group type: EXPERIMENTAL
Intervention: Selatogrel 8 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Selatogrel 16 mg
Number of subjects: 47
Study: 36183482

Group type: EXPERIMENTAL
Intervention: Personalized nutrition intervention combined with telephone‐based education for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care with telephone follow-up after 6 months
Number of subjects: 60
Study: 32710658

Group type: EXPERIMENTAL
Intervention: HELP-LTC (n = 105)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Usual care (n = 114)
Number of subjects: 219
Study: 36480957

Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Unsupervised training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 33960511

Group type: EXPERIMENTAL
Intervention: Levodoa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dopamine agonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monoamine oxidase type B inhibitors
Number of subjects: 0
Study: 32404633

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 32
Study: 35172988

Group type: EXPERIMENTAL
Intervention: Prior OAC use
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Apixaban (vs VKA) with prior OAC use
Number of subjects: 4614
Study: 33740922

Group type: EXPERIMENTAL
Intervention: Equine-Assisted Activities (EAA), 40-minute sessions twice a week for 16 weeks.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (daily life without special treatments).
Number of subjects: 46
Study: 32605909

Group type: EXPERIMENTAL
Intervention: Standard-dose pembrolizumab (2 mg/kg amended to 200 mg) plus reduced-dose ipilimumab (1 mg/kg) every 3 weeks for four cycles, then pembrolizumab alone for up to 2 years
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Standard-dose pembrolizumab plus reduced-dose ipilimumab
Number of subjects: 153